comparemela.com

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Approximately 8.1% of the shares of the company are sold short. Based on […]

Related Keywords

Geoffreym Parker ,Frank Karbe ,Nasdaq ,Vanguard Group Inc ,Better Therapeutics Company Profile ,Better Therapeutics Inc ,Better Therapeutics ,Get Rating ,Lake Street Capital ,Therapeutics Stock Down ,Director Geoffrey ,Better Therapeutics Daily ,Nasdaq Bttx ,Bttx ,Medical ,Stocks ,Options ,Put ,Call ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.